Roberta Bordone Pittau

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) PI3Kδ activation, IL6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas

Blood Advances, 7 ottobre 2024

2) ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms

bioRxiv, 2 gennaio 2023

Facts & figures

Roberta Bordone Pittau has coordinated or participated in 2 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) whose subjects can be represented by this 1 elements tag cloud:

B cell lymphoid (1)

Roberta Bordone Pittau has coordinated or participated in 2 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) featured by 2 scientific journals:

bioRxiv (1) Blood Advances (1)

Roberta Bordone Pittau has coordinated or participated in 2 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) involving also 22 co-authors being active in Ticino:

Sara Napoli (2) Georg Stüssi (2) Eugenio Gaudio (2) Eleonora Cannas (2) Chiara Tarantelli (2) Luciano Cascione (2) Francesco Bertoni (2) Emanuele Zucca (2) Davide Rossi (2) Andrea Rinaldi (2) Anastasios Stathis (2) Nicolas Munz (1) Jacopo Sgrignani (1) Laura Barnabei (1) Filippo Spriano (1) Andrea Cavalli (1) Afua Adjeiwaa Mensah (1) Alberto J. Arribas (1) Ivo Kwee (1) Sandra Jovic (1) Giulio Sartori (1) Alberto Jesus Arribas (1)

Roberta Bordone Pittau has coordinated or participated in 2 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) in whose synopsis the 13 most frequently used terms (excluding 15 not relevant terms) are here listed:

R.B.P. WORD CLOUD pi (2) overexpression (1) cause (1) naratuximab (1) emtansine (1) lymphomas (1) erbb (1) mediated (1) signaling (1) mediator (1) btk (1) lymphoid (1) neoplasms (1)

In the synopsis of the whole 3332 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations), the 197 most frequently used terms (excluding 15 not relevant or unfrequently used terms (terms used less than 10 times) are here listed:

THE WHOLE WORD CLOUD cancer (299) covid- (186) thyroid (111) pet (109) cardiac (107) prostate (107) sars-cov- (103) hiv (89) atrial (81) breast (81) coronary (79) sclerosis (76) fibrillation (69) lymphoma (68) pandemic (67) bone (54) aortic (52) heart (51) artery (51) stroke (50) liver (47) carcinoma (46) brain (44) antibodies (42) cardiovascular (41) lung (40) mri (39) transcatheter (36) metastatic (35) dna (35) ventricular (35) kidney (34) nodules (34) tumor (33) extracellular (33) virus (33) myocardial (32) knee (31) ultrasound (30) oncology (30) mitral (27) antibody (27) esmo (27) percutaneous (26) f-fdg (26) hepatitis (25) vesicles (25) spinal (25) antiplatelet (24) cervical (24) ischemic (24) osteoarthritis (23) tuberculosis (23) diabetes (23) infarction (23) chemotherapy (23) ovarian (22) sentinel (22) radiotherapy (22) bladder (22) pulmonary (22) sperm (22) ehra (22) endovascular (21) implantation (21) transplantation (21) vaccination (21) renal (21) blood (20) lymph (19) resonance (19) plasma (19) tomography (19) urinary (19) bacterial (19) b-cell (18) monoclonal (18) nuclear (18) tumors (18) pacing (18) fdg (17) colorectal (17) laparoscopic (17) mice (17) implantable (16) autoimmune (16) vaccine (16) transplant (16) coronavirus (16) immunodeficiency (16) radiomics (15) membrane (15) preclinical (15) metabolic (15) metabolism (15) vascular (15) musculoskeletal (15) tricuspid (14) endometrial (14) pneumonia (14) antiretroviral (14) biomarker (14) serum (14) mrna (14) metastasis (14) lymphomas (14) fractures (14) peripheral (14) neurocognitive (14) leukemia (14) occlusion (13) male (13) behavior (13) muscle (13) interventions (13) legs (13) radiation (13) arterial (13) hemorrhage (13) nerve (13) biomarkers (13) pregnancy (13) lymphocytic (13) medullary (12) malignant (12) platelet-rich (12) hiv- (12) metastases (12) tau (12) iga (12) conference (12) mutations (12) malignancy (12) brugada (12) joint (12) fna (12) grafts (12) ischemia (12) dementia (12) esc (12) radiology (11) baseline (11) gastric (11) intravenous (11) arrhythmia (11) dynamic (11) incontinence (11) burden (11) pi (11) contemporary (11) contrast-enhanced (11) pathways (11) adherence (11) catheter (11) parkinson (11) limb (11) cytology (11) signaling (11) neck (11) mesenchymal (11) senescence (11) lockdown (11) il- (11) administration (10) overview (10) regurgitation (10) depression (10) art (10) idiopathic (10) clonal (10) bayesian (10) checkpoint (10) antithrombotic (10) precision (10) recovery (10) possible (10) prognosis (10) cancers (10) vascularized (10) adapted (10) peptide (10) ecg (10) infectious (10) fixation (10) prolapse (10) pci (10) hip (10) migraine (10) skin (10) prophylaxis (10) follicular (10) igg (10) vitamin (10) epidemiology (10) lipid (10) refractory (10) anesthesia (10)

Roberta Bordone Pittau has coordinated or participated in the 2 publications here listed (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations)

1) PI3Kδ activation, IL6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas

2) ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms

Roberta Bordone Pittau has coordinated or participated in the 2 publications here listed
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations)